Potassium channel openers: airway pharmacology and clinical possibilities in asthma. - Suppr | 超能文献

Potassium channel openers: airway pharmacology and clinical possibilities in asthma.

作者信息

Raeburn D, Karlsson J A

机构信息

Rhône-Poulenc Rorer Ltd., Dagenham Research Centre, Essex, England.

出版信息

Prog Drug Res. 1991;37:161-80. doi: 10.1007/978-3-0348-7139-6_4.

DOI:10.1007/978-3-0348-7139-6_4

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Potassium channel openers: airway pharmacology and clinical possibilities in asthma.

Prog Drug Res. 1991;37:161-80. doi: 10.1007/978-3-0348-7139-6_4.

2

The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.钾通道调节剂在哮喘和慢性阻塞性肺疾病中的潜在治疗作用。

J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):123-30.

3

K+ channel openers and suppression of airway hyperreactivity.钾离子通道开放剂与气道高反应性的抑制

Trends Pharmacol Sci. 1994 Dec;15(12):463-8. doi: 10.1016/0165-6147(94)90060-4.

4

K+-channel opening as a mechanism for relaxing airways smooth muscle.

Agents Actions Suppl. 1988;23:89-94.

5

Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease.钾通道开放剂在哮喘和慢性阻塞性肺疾病治疗中的潜在作用。

Life Sci. 2002 Jan 18;70(9):977-90. doi: 10.1016/s0024-3205(01)01487-4.

6

Potassium channels in airway smooth muscle: a tale of two channels.气道平滑肌中的钾通道：两种通道的故事。

Pharmacol Ther. 1993;58(1):1-12. doi: 10.1016/0163-7258(93)90064-k.

7

Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.三种新型钾通道开放剂（克罗卡林、匹那地尔和尼可地尔）对过敏反应和实验性哮喘的影响。

Jpn J Pharmacol. 1991 May;56(1):13-21. doi: 10.1254/jjp.56.13.

8

Potassium channel openers and asthma.钾通道开放剂与哮喘

Clin Rev Allergy. 1994 Spring;12(1):109-20. doi: 10.1007/BF02815513.

9

TRP channels in airway smooth muscle as therapeutic targets.气道平滑肌中的瞬时受体电位通道作为治疗靶点。

Naunyn Schmiedebergs Arch Pharmacol. 2005 Apr;371(4):277-84. doi: 10.1007/s00210-005-1058-2.

10

Clinical pharmacology of potassium channel openers.钾通道开放剂的临床药理学

Pharmacol Toxicol. 1992 Apr;70(4):244-54. doi: 10.1111/j.1600-0773.1992.tb00466.x.

引用本文的文献

1

KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation.KATP通道开放剂可逆转免疫复合物诱导的气道高反应性，且与平滑肌舒张无关。

Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):355-61. doi: 10.1007/BF00171068.

2

Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats.豚鼠和大鼠体内钾通道激活剂BRL 55834和左旋克罗卡林（BRL 38227）的气道舒张和降压效力比较

Br J Pharmacol. 1993 Aug;109(4):1133-9. doi: 10.1111/j.1476-5381.1993.tb13740.x.